LiDCO shares fall after saying it expects 2017 loss
A look at some of today's top risers and fallers in London today
Company
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
328 stories · page 3 of 4
A look at some of today's top risers and fallers in London today
Dutch group ISA Pharmaceutical will incorporate its Amplivant technology into Modi-1, the first cancer treatment candidate being developed on the platform
Investments and investor services
The UK's blue-chip index closes up 20.84 points to 7,234.81
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Immuno-therapy SCIB1, which is expected to progress into Phase II clinical trials in the second-half of the year, was the focus of a peer-reviewed paper in OncoImmunology
Investments and investor services
The index of blue-chip shares eased off a little in the final half-hour
Archive
While the blue-chips were shaken, with a fall of 3.8% over the trading week, shares in the UK’s growth sector were even harder hit with the AIM All Share off 4.5%
Archive
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Friday
Once formally granted, the patent will provide protection for Scancell’s pipeline of Moditope vaccines
The US rally fizzled out prompting a late sell-off in an already below-water London
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and falls on the London market today
The Cancer Research UK Grand Challenge is a prestigious award that brings with it significant funding
Investments and investor services
The FTSE 100 index – which is chock full of dollar earners – closed around 108 points lower at 7,170
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Tuesday...
Patient enrolment for the SCIB1 Phase 2 checkpoint inhibitor combination study for patients with advanced melanoma is planned to start in the second half of the year
FTSE 100, which has been hitting record highs over the past weeks, hit a five week low
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
The research collaboration will combine Scancell’s Moditope immunotherapy platform and BioNTech’s platform technology for high-throughput cloning and characterisation of naturally selected T cell receptors
London's top tier index reached a new record high on Tuesday, led by supermarket shares
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
“We are delighted to announce this partnership with Cancer Research UK, which is a significant endorsement for our ImmunoBody technology”
Investments and investor services
Cancer Research UK was immensely impressed with the company and its technology
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The FTSE 100 closed out Thursday up around 67 points at 7,555.
A look at some of the biggest risers and fallers today in London
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
Executive chairman John Chiplin said new CEO Dr Cliff Holloway's extensive experience and accomplishments speak volumes
The UK benchmark finished the day at 7,538, up 30.38 points
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the main news driven risers and fallers at 3.40pm…
“We are continuing to explore a number of funding options to ensure that we have the resources to progress these programmes through their next phase”
The heavyweight dragged on the FTSE 100, which closed down 20.99 points
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Chief scientific officer Lindy Durrant presented two posters at the International Cancer Immunotherapy conference in Germany on Friday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell has revealed that using Oncimmune's autoantibody technology may help to identify patients who are most likely to respond to its SCIB1 skin cancer treatment in future trials
Investments and investor services
FTSE 100 closed Tuesday's afternoon session 64 points lower at 7,337
Archive
A glance at some of the stories on the Proactive newswire today...
Investments and investor services
Shares featured: Jangada, Ilika, Carillion, Matomy Media, Bagir Group, Abzena, Bango, Galliford Try, Highlands Natural Resources
Eight patients have now reached the five year survival milestone, with half of those not seeing any recurrence of the disease during that time
The market chose to interpret Broadbent's comments as a vote for the status quo
A look at some of the biggest London-listed risers and fallers today
The money will support clinical work on its pipeline of cancer immunotherapies and in particular Modi-1, the first product from its Moditope platform.
SyndicateRoom will offer shares in DSM to its members on the same terms as the institutional investors
Investments and investor services
Around 3.30pm, the FTSE 100 index was up almost 28 points at 7,371, just below the day’s best level of 7,376, having only hit a low of 7,342
Archive
Eland Oil & Gas kicks off production at Opuama field; Stride Gaming is targeting a bigger piece of the bingo pie; Motif Bio passes a major landmark; Avesoro secures favourable revised lending terms plus much more…
The update was provided as Scancell served up its financial results for the six months ended October 31.
Archive
Gfinity gets Mediacom on board for e-sports project; Scancell inks collaboration deal with leading US lung cancer foundation; and Richland Resources beats production targets at Capricorn mine
"In our view, the potential for SCIB1 [Scancell's skin cancer treatment], as already demonstrated by the survival data, is remarkable," said one broker recently
It is teaming up with the Addario Lung Cancer Medical Institute (ALCMI) and the Bonnie J Addario Lung Cancer Foundation.
Archive
A glance at some of the stories on the Proactive newswire today
The study showed the response to SCIB1 was “significantly stronger” at higher doses, while the drug worked better for those patients who already had the tumour removed before treatment.
A glance at today's Proactive small -cap stories from the newswire
Main share price risers and fallers in London at 4pm
Investments and investor services
FTSE 100 shares came within a handful of points of marking a fresh record high close on Monday, but for all the gains of mining stocks the ticker just could not muster the umph to triumph
Daily summary of some of the top Proactive news headlines.
Daily round up of the day's news headlines from Proactive Investors.
LGO Energy has successfully recompleted the GY-277 well, Image Scan is on track to break even, and Avation has purchased and delivered another brand new Airbus.
Dr Alan Lewis brings "a wealth of industry experience, both commercially and financially," said Scancell chairman Dr John Chiplin
A round-up of small cap newswire storiest today on Proactive
Scancell wants the drugs for a US clinical study of SCIB1 in combination with a checkpoint inhibitor
Scancell will continue to use Ichor’s electroporation delivery system in conjunction with its flagship skin cancer vaccine.
Berkeley Energia suspends shares, KEFI Minerals shuffles its board, and Scancell's technology is highlighted by the scientific community.
“We believe this platform has the potential to develop a new class of immuno-oncology therapeutics and look forward to progressing our first vaccine into the clinic as soon as possible."
Archive
London’s FTSE 100 closed down on Wednesday in a repeat of the previous session’s gyrations over the ongoing Brexit vote shock
Archive
Hummingbird begins detailed engineered at Yanfolila; Shanta Gold exploration yields some encouraging results; Breedon Aggregates proposes a name change; and more…
With cases of skin cancer on the rise, Scancell's immunotherapy study data has come at the right time, but is it enough to offset the insecurity in the sector?
Investments and investor services
The FTSE 100 Index reversed modest gains to stand 103.29 points adrift at 6442.08
A first look at some of the notable market movers on Wednesday
The FTSE 100 Index increased 11.54 points to 6556.91
Chief executive Dr Richard Goodfellow told investors that the drug continues to deliver compelling survival data in patients
The FTSE100 index popped its head above 6,000 early in the session and managed to stay there into the Friday close, drawing and end to a difficult Brexit fears week
Footsie is on track to finish a rough week on a positive note
Main share price risers and fallers in London at 3.45pm
The company said that quality control analysis revealed the “stored drug product is no longer within the original specification”.
Banks lead the way higher as fears of a Brexit recede
Glioblastoma multiforme is one of the most common and most aggressive forms of brain cancer.
The FTSE 100 surrendered all of May's gains to close 10 points down on the month
The FTSE 100 Index trod water as traders shrugged off mixed economic data from the continent
Today was effectively a wash-out for equities, with the Footsie barely changed
Strategic Minerals begins drilling in Australia, Haydale agrees a partnership with plasma reactor group and Scancell has a management reshuffle.
Investments and investor services
Footsie falls 40 points but Goals Soccer Centres lifts nearly 10%
Investments and investor services
Mining stocks weighed on the Footsie but Capital Drilling offered some hope for the beleaguered sector
AstraZeneca has reportedly held talks with San Francisco-based Medivation
Scancell Holdings PLC revealed it had raised a total of around £6.2mln from its open offer and share placing. n.
Archive
Keywords Studios unlocks China, Metal Tiger shares rise and a successful fundraiser from cancer-fighting Scancell.
"We have pioneered this new model of share distribution - giving brokers and companies access to previously untapped retail demand,” said Tom Hinton, SyndicateRoom's head of capital markets.
Archive
Fastjet mulls response to shareholder, Shanta Gold reaches a milestone and BATM was back in the black.
Dr Peter Brown, Scancell's clinical and scientific consultant on Immunotherapeutics, will give a presentation entitled: "SCIB1 ImmunoBody stimulates a potent T cell response that eradicates tumours and prevents recurrence".
Investments and investor services
Aim's leading lights ended a rough week on a bright note